Fingerprint
Dive into the research topics of 'Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
the Consortium of Investigators of Modifiers of BRCA and BRCA2, Mary Daly
- University of Cambridge
- Netherlands Cancer Institute
- Leeds Teaching Hospitals NHS Trust
- Great Ormond Street Hospital for Children NHS Foundation Trust
- University of Helsinki
- Genetic Epidemiology of Cancer team
- Institut Curie
- Mines ParisTech
- Université PSL
- Fred A. Litwin Center for Cancer Genetics
- University of Toronto
- Kiel University
- University of Texas MD Anderson Cancer Center
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Vall d'Hebron Institute of Oncology
- University Hospital Vall d’Hebron
- Landspitali University Hospital
- University of Iceland
- Center for Biomedical Network Research on Rare Diseases (CIBERER)
- Biomedical Network on Rare Diseases (CIBERER)
- Georges François Leclerc Cancer Center
- Pomeranian Medical University in Szczecin
- University of California at San Francisco
- Maastricht University
- IRCCS Istituto Europeo di Oncologia - Milano
- Sjællands Universitetshospital
- Lund University
- National Institute of Oncology
- University of Pennsylvania
- Newcastle University
- Royal Devon & Exeter NHS Foundation Trust
- Centro de Investigación Biomédica en Red de Cáncer
- University of Utah
- Hospital Clínico San Carlos de Madrid
- University of Pisa
- Peter Maccallum Cancer Centre
- University of Melbourne
- Aarhus University
- Columbia University
- Ghent University
- Université de Franche-Comté
- CHU Nantes
- Centre de Recherche en Cancérologie de Lyon
- Centre Léon Bérard
- Centre Antoine Lacassagne
Research output: Contribution to journal › Article › peer-review
90
Scopus
citations